{"transactions":[{"id":2826,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-03T20:48:33.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":1864,"price":42.97,"value":80096.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 2, 2026."}],"balance_after":42718,"source":{"system":"sec-edgar","filing":"0001846905-26-000006","document":"wk-form4_1788468511.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1846905/000184690526000006/wk-form4_1788468511.xml","form_type":"4"}},{"id":731926,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-18T20:04:04.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":39715,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":39715,"derivative":{"exercise_price":5.67,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":39715},"source":{"system":"sec-edgar","filing":"0001846905-26-000004","document":"wk-form4_1781813041.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000184690526000004/wk-form4_1781813041.xml","form_type":"4"}},{"id":731925,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T20:04:04.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":26455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program."}],"balance_after":163808,"source":{"system":"sec-edgar","filing":"0001846905-26-000004","document":"wk-form4_1781813041.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000184690526000004/wk-form4_1781813041.xml","form_type":"4"}},{"id":737536,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-15T20:55:45.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":5272,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units awarded on June 11, 2026 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier.  In addition, the restricted stock units vest in full in the event of a change in control of the Issuer."}],"balance_after":44582,"source":{"system":"sec-edgar","filing":"0001846905-26-000002","document":"wk-form4_1781556942.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000184690526000002/wk-form4_1781556942.xml","form_type":"4"}},{"id":743091,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-10T22:57:33.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":13300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 9, 2026 with respect to 13,300 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":13300,"derivative":{"exercise_price":12.89,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":13300},"source":{"system":"sec-edgar","filing":"0001193125-26-266230","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000119312526266230/ownership.xml","form_type":"4"}},{"id":743090,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T22:57:33.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":9200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":36403,"source":{"system":"sec-edgar","filing":"0001193125-26-266230","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000119312526266230/ownership.xml","form_type":"4"}},{"id":762485,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-05-27T23:16:17.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":4301,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4301,"derivative":{"exercise_price":77.15,"exercise_date":"2026-06-28","expiration_date":"2036-05-26","underlying":"Common Stock","underlying_shares":4301},"source":{"system":"sec-edgar","filing":"0001061983-26-000062","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000062/form4.xml","form_type":"4"}},{"id":762484,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-27T23:16:17.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":2851,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":26361,"source":{"system":"sec-edgar","filing":"0001061983-26-000062","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000062/form4.xml","form_type":"4"}},{"id":1103631,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T00:39:01.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":54059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":54059,"derivative":{"exercise_price":3.61,"expiration_date":"2035-06-18","underlying":"Common Stock","underlying_shares":54059},"source":{"system":"sec-edgar","filing":"0001628280-25-032725","document":"wk-form4_1750725535.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000162828025032725/wk-form4_1750725535.xml","form_type":"4"}},{"id":1103630,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T00:39:01.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":41551,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.  The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program."}],"balance_after":137353,"source":{"system":"sec-edgar","filing":"0001628280-25-032725","document":"wk-form4_1750725535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000162828025032725/wk-form4_1750725535.xml","form_type":"4"}},{"id":1103526,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-23T20:09:42.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":9321,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units awarded on June 18, 2025 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier.  In addition, the restricted stock units vest in full in the event of a change in control of the Issuer."}],"balance_after":39310,"source":{"system":"sec-edgar","filing":"0001384101-25-000094","document":"wk-form4_1750709375.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410125000094/wk-form4_1750709375.xml","form_type":"4"}},{"id":1107612,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-17T20:21:02.000Z","date":"2025-06-13","kind":"sale","planned":true,"acquired":false,"shares":4589,"price":26.6652,"value":122366.6028,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average sales price.  Sale prices for the transactions range from $26.39 to $26.92.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":29989,"source":{"system":"sec-edgar","filing":"0001384101-25-000079","document":"wk-form4_1750191655.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410125000079/wk-form4_1750191655.xml","form_type":"4"}},{"id":1111607,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-13T20:27:14.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":11450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 11, 2025 with respect to  11,450 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":11450,"derivative":{"exercise_price":8.37,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":11450},"source":{"system":"sec-edgar","filing":"0000950170-25-086243","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017025086243/ownership.xml","form_type":"4"}},{"id":1111606,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T20:27:14.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":27203,"source":{"system":"sec-edgar","filing":"0000950170-25-086243","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017025086243/ownership.xml","form_type":"4"}},{"id":1147990,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-15T22:51:22.000Z","date":"2025-05-15","kind":"sale","planned":true,"acquired":false,"shares":1454,"price":29.73,"value":43227.42,"ownership":{"direct":true},"balance_after":23510,"source":{"system":"sec-edgar","filing":"0001127602-25-014556","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225014556/form4.xml","form_type":"4"}},{"id":1149748,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2025-05-14T23:42:00.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":10880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Comprised of stock options that will vest monthly in equal installments over a period commencing on the grant date and ending on the earlier to occur of (x) the one-year anniversary of the date of the grant and (y) the date of the issuer's annual meeting of stockholders for the calendar year immediately subsequent to the grant date, subject to the director's continuous service as a member of the issuer's Board of Directors."}],"balance_after":10880,"derivative":{"exercise_price":30,"exercise_date":"2025-06-16","expiration_date":"2035-05-13","underlying":"Common Stock","underlying_shares":10880},"source":{"system":"sec-edgar","filing":"0001127602-25-014365","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225014365/form4.xml","form_type":"4"}},{"id":1149747,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-14T23:42:00.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":7333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Comprised of restricted stock units (\"RSUs\") that will vest in one installment on the earlier to occur of (x) the one-year anniversary of the grant date and (y) the date of the issuer's annual meeting of stockholders for the calendar year immediately subsequent to the grant date, subject to the director's continuous service as a member of the issuer's Board of Directors. RSUs convert to shares of common stock on a 1:1 basis upon vesting."}],"balance_after":24964,"source":{"system":"sec-edgar","filing":"0001127602-25-014365","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225014365/form4.xml","form_type":"4"}},{"id":1162427,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-01T20:24:22.000Z","date":"2025-04-29","kind":"sale","planned":true,"acquired":false,"shares":265,"price":8.5,"value":2252.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sale of 265 shares on this Form 4 occurred automatically pursuant to a 10b5-1 trading plan adopted by the reporting person on September 27, 2024."}],"balance_after":19203,"source":{"system":"sec-edgar","filing":"0000950170-25-061881","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017025061881/ownership.xml","form_type":"4"}},{"id":1289484,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-31T21:17:16.000Z","date":"2025-01-29","kind":"sale","planned":true,"acquired":false,"shares":265,"price":9.97,"value":2642.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sale of 265 shares on this Form 4 occurred automatically pursuant to a 10b5-1 trading plan adopted by the reporting person on September 27, 2024."}],"balance_after":19468,"source":{"system":"sec-edgar","filing":"0000950170-25-011757","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017025011757/ownership.xml","form_type":"4"}},{"id":1477194,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-17T22:53:21.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":40243,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":40243,"derivative":{"exercise_price":6.35,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":40243},"source":{"system":"sec-edgar","filing":"0001628280-24-028602","document":"wk-form4_1718664795.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000162828024028602/wk-form4_1718664795.xml","form_type":"4"}},{"id":1476966,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-17T20:48:37.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":11473,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units awarded on June 13, 2024 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer."}],"balance_after":34578,"source":{"system":"sec-edgar","filing":"0001384101-24-000102","document":"wk-form4_1718657310.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410124000102/wk-form4_1718657310.xml","form_type":"4"}},{"id":1478958,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-14T20:18:01.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":11515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 12, 2024 with respect to 11,515 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":11515,"derivative":{"exercise_price":25.85,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":11515},"source":{"system":"sec-edgar","filing":"0000950170-24-073685","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017024073685/ownership.xml","form_type":"4"}},{"id":1478957,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T20:18:01.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":7737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":19733,"source":{"system":"sec-edgar","filing":"0000950170-24-073685","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017024073685/ownership.xml","form_type":"4"}},{"id":1483117,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-11T20:22:08.000Z","date":"2024-06-10","kind":"sale","planned":true,"acquired":false,"shares":3870,"price":20.3188,"value":78633.756,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 27, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average sales price.  Sale prices for the transactions range from $19.97 to $20.88.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":23105,"source":{"system":"sec-edgar","filing":"0001384101-24-000086","document":"wk-form4_1718137320.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410124000086/wk-form4_1718137320.xml","form_type":"4"}},{"id":1485471,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-10T20:15:06.000Z","date":"2024-06-10","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":52.07,"value":104140.0,"ownership":{"direct":true},"balance_after":17631,"source":{"system":"sec-edgar","filing":"0001127602-24-018246","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224018246/form4.xml","form_type":"4"}},{"id":1497572,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-30T20:41:46.000Z","date":"2024-05-28","kind":"sale","planned":true,"acquired":false,"shares":1539,"price":21,"value":32319.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 27, 2024."}],"balance_after":26975,"source":{"system":"sec-edgar","filing":"0001384101-24-000069","document":"wk-form4_1717101697.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410124000069/wk-form4_1717101697.xml","form_type":"4"}},{"id":1514791,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2024-05-16T22:17:51.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":3636,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3636,"derivative":{"exercise_price":60.5,"exercise_date":"2024-06-17","expiration_date":"2034-05-15","underlying":"Common Stock","underlying_shares":3636},"source":{"system":"sec-edgar","filing":"0001127602-24-015725","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224015725/form4.xml","form_type":"4"}},{"id":1514790,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-16T22:17:51.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":5600,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19631,"source":{"system":"sec-edgar","filing":"0001127602-24-015725","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224015725/form4.xml","form_type":"4"}},{"id":1751340,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-02T20:42:59.000Z","date":"2023-10-31","kind":"sale","planned":true,"acquired":false,"shares":265,"price":23.9,"value":6333.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sale of 265 shares on this Form 4 occurred automatically pursuant to a 10b5-1 trading plan adopted by the reporting person on March 8, 2023."}],"balance_after":11996,"source":{"system":"sec-edgar","filing":"0001209191-23-054163","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919123054163/doc4.xml","form_type":"4"}},{"id":1817906,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-02T21:19:39.000Z","date":"2023-07-31","kind":"sale","planned":true,"acquired":false,"shares":265,"price":42.33,"value":11217.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sale of 265 shares on this Form 4 occurred automatically pursuant to a 10b5-1 trading plan adopted by the reporting person on March 8, 2023."}],"balance_after":12261,"source":{"system":"sec-edgar","filing":"0001209191-23-044257","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919123044257/doc4.xml","form_type":"4"}},{"id":1832221,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-10T21:21:43.000Z","date":"2023-07-06","kind":"sale","planned":true,"acquired":false,"shares":1867,"price":39.3,"value":73373.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sale of 1,867 shares on this Form 4 occurred automatically pursuant to a 10b5-1 trading plan adopted by the reporting person on March 8, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.84 to $39.74, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 6, 2023 at each separate price."}],"balance_after":12526,"source":{"system":"sec-edgar","filing":"0001209191-23-041951","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919123041951/doc4.xml","form_type":"4"}},{"id":1833154,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-07-07T20:17:24.000Z","date":"2023-07-07","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":34.1173,"value":68234.6,"ownership":{"direct":true},"balance_after":14031,"source":{"system":"sec-edgar","filing":"0001127602-23-020455","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223020455/form4.xml","form_type":"4"}},{"id":1847584,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-21T20:55:37.000Z","date":"2023-06-16","kind":"sale","planned":true,"acquired":false,"shares":100,"price":27.09,"value":2709.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 27, 2023."}],"balance_after":28514,"source":{"system":"sec-edgar","filing":"0001384101-23-000128","document":"wk-form4_1687380927.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410123000128/wk-form4_1687380927.xml","form_type":"4"}},{"id":1847583,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-21T20:55:37.000Z","date":"2023-06-16","kind":"sale","planned":true,"acquired":false,"shares":5793,"price":26.4244,"value":153076.5492,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average sales price.  Sale prices for the transactions range from $26.08 to $27.07.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":28614,"source":{"system":"sec-edgar","filing":"0001384101-23-000128","document":"wk-form4_1687380927.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410123000128/wk-form4_1687380927.xml","form_type":"4"}},{"id":1851968,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T22:32:04.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":49237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":49237,"derivative":{"exercise_price":3.92,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":49237},"source":{"system":"sec-edgar","filing":"0001628280-23-022558","document":"wk-form4_1686954708.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000162828023022558/wk-form4_1686954708.xml","form_type":"4"}},{"id":1852190,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T20:24:24.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":6473,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 14, 2023 with respect to 6,473 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":6473,"derivative":{"exercise_price":45.2,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":6473},"source":{"system":"sec-edgar","filing":"0001209191-23-037860","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919123037860/doc4.xml","form_type":"4"}},{"id":1852189,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:24:24.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":4425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":14393,"source":{"system":"sec-edgar","filing":"0001209191-23-037860","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919123037860/doc4.xml","form_type":"4"}},{"id":1856957,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-13T21:21:15.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":9674,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units awarded on June 9, 2023 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer."}],"balance_after":34407,"source":{"system":"sec-edgar","filing":"0001384101-23-000122","document":"wf-form4_168669126274077.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410123000122/wf-form4_168669126274077.xml","form_type":"4"}},{"id":1871702,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-01T21:06:20.000Z","date":"2023-05-30","kind":"sale","planned":false,"acquired":false,"shares":1539,"price":25.91,"value":39875.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 27, 2023."}],"balance_after":24733,"source":{"system":"sec-edgar","filing":"0001384101-23-000072","document":"wf-form4_168565356637516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410123000072/wf-form4_168565356637516.xml","form_type":"4"}},{"id":1887362,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2023-05-18T20:33:18.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Options shall vest and become exercisable in 12 equal monthly installments, the first such installment vesting on 06/10/2023 and the last such installment vesting on 05/10/2024."}],"balance_after":10000,"derivative":{"exercise_price":37.89,"exercise_date":"2023-06-10","expiration_date":"2033-05-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001127602-23-016157","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223016157/form4.xml","form_type":"4"}},{"id":1887361,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-18T20:33:18.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Comprised of restricted stock units that will vest in full and in one installment on 05/10/2024."}],"balance_after":16031,"source":{"system":"sec-edgar","filing":"0001127602-23-016157","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223016157/form4.xml","form_type":"4"}},{"id":2142687,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-10-05T20:18:45.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":220,"price":51.11,"value":11244.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $51.11, representing the closing stock price of the Issuer's common stock on October 3, 2022."}],"balance_after":11031,"source":{"system":"sec-edgar","filing":"0001127602-22-023697","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760222023697/form4.xml","form_type":"4"}},{"id":2208734,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-07-12T20:08:18.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":274,"price":41,"value":11234.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $41.00, representing the closing stock price of the Issuer's common stock on July 1, 2022."}],"balance_after":10811,"source":{"system":"sec-edgar","filing":"0001127602-22-019228","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760222019228/form4.xml","form_type":"4"}},{"id":2227510,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-17T20:21:00.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":100000,"derivative":{"exercise_price":0.548,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001567619-22-013084","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000156761922013084/doc1.xml","form_type":"4"}},{"id":2227509,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T20:21:00.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":95802,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program."}],"balance_after":95802,"source":{"system":"sec-edgar","filing":"0001567619-22-013084","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000156761922013084/doc1.xml","form_type":"4"}},{"id":2229619,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T00:12:18.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":14731,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units awarded on June 16, 2022 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer."}],"balance_after":26272,"source":{"system":"sec-edgar","filing":"0001384101-22-000096","document":"wf-form4_165542471995449.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000096/wf-form4_165542471995449.xml","form_type":"4"}},{"id":2229939,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T22:19:22.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":2980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 14, 2022 with respect to 2,980 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":2980,"derivative":{"exercise_price":38.49,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":2980},"source":{"system":"sec-edgar","filing":"0001209191-22-037588","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919122037588/doc4.xml","form_type":"4"}},{"id":2229938,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-16T22:19:22.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":2014,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":9968,"source":{"system":"sec-edgar","filing":"0001209191-22-037588","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919122037588/doc4.xml","form_type":"4"}},{"id":2275143,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-05-11T22:04:29.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options shall vest and become exercisable in 12 equal monthly installments, the first such installment vesting on 06/10/2022 and the last such installment vesting on 05/10/2023."}],"balance_after":10000,"derivative":{"exercise_price":37.89,"expiration_date":"2032-05-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001061983-22-000115","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000115/edgardoc.xml","form_type":"4"}},{"id":2275142,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-11T22:04:29.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Comprised of restricted stock units that will vest in full and in one installment on 05/10/2023."}],"balance_after":10537,"source":{"system":"sec-edgar","filing":"0001061983-22-000115","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000115/edgardoc.xml","form_type":"4"}},{"id":2286453,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-03T01:49:32.000Z","date":"2022-04-28","kind":"grant","acquired":true,"shares":11700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on April 28, 2022 with respect to 11,700 shares of Common Stock pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan, with 33 1/3 % vesting on April 28, 2023 and the\nremaining 66 2/3% vesting in 8 substantially equal quarterly installments thereafter."}],"balance_after":11700,"derivative":{"exercise_price":50.29,"expiration_date":"2032-04-27","underlying":"Common Stock","underlying_shares":11700},"source":{"system":"sec-edgar","filing":"0001209191-22-026561","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919122026561/doc4.xml","form_type":"4"}},{"id":2286452,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-03T01:49:32.000Z","date":"2022-04-28","kind":"grant","acquired":true,"shares":7954,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":7954,"source":{"system":"sec-edgar","filing":"0001209191-22-026561","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919122026561/doc4.xml","form_type":"4"}},{"id":2311776,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-01T23:16:40.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":293,"price":38.38,"value":11245.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are fully vested from the moment of grant. Shares issued at per share price of $38.38, representing the Issuer's closing stock price on April 1, 2022."}],"balance_after":5537,"source":{"system":"sec-edgar","filing":"0001061983-22-000086","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000086/edgardoc.xml","form_type":"4"}},{"id":2450724,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-04T21:46:32.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":244,"price":46,"value":11224.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are full vested from the moment of grant. Shares issued at per share price of $46.00, representing the Issuer's closing stock price on January 3, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 244 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":5244,"source":{"system":"sec-edgar","filing":"0001061983-22-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000008/edgardoc.xml","form_type":"4"}},{"id":2714981,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-05-14T00:01:08.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options shall vest and become exercisable in 12 equal monthly installments, the first such installment vesting on 06/12/2021 and the last such installment vesting on 05/12/2022."}],"balance_after":10000,"derivative":{"exercise_price":24.32,"exercise_date":"2021-06-12","expiration_date":"2031-05-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001061983-21-000136","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000136/edgardoc.xml","form_type":"4"}},{"id":2714980,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-14T00:01:08.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Comprised of restricted stock units that will vest in full and in one installment on 05/12/2022."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001061983-21-000136","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000136/edgardoc.xml","form_type":"4"}},{"id":2774254,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-23T20:48:12.000Z","date":"2021-03-19","kind":"grant","acquired":true,"shares":11541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units awarded on March 19, 2021 vest as to one-third (1/3) of the shares on each of the first, second and third annual anniversaries of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's common stock upon settlement."}],"balance_after":11541,"source":{"system":"sec-edgar","filing":"0001384101-21-000055","document":"wf-form4_161653247749352.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000055/wf-form4_161653247749352.xml","form_type":"4"}},{"id":2789091,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-15T20:47:12.000Z","date":"2021-03-11","kind":"grant","acquired":true,"shares":63687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 36 successive, equal monthly installments on each monthly anniversary of March 11, 2021, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":63687,"derivative":{"exercise_price":7.01,"expiration_date":"2031-03-11","underlying":"Common Stock","underlying_shares":63687},"source":{"system":"sec-edgar","filing":"0001567619-21-006314","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000156761921006314/doc1.xml","form_type":"4"}},{"id":2851599,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":2019,"kind":"person","name":"Bhanji Muna","position":1,"cik":"0001846905","reported_name":"Bhanji Muna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-02-19T01:28:39.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":35000,"price":21.86,"value":765100.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest and become exercisable in 36 equal monthly installments as from the date of the grant."}],"balance_after":35000,"derivative":{"exercise_price":21.86,"exercise_date":"2021-03-17","expiration_date":"2031-02-17","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001061983-21-000030","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000030/edgardoc.xml","form_type":"4"}}]}